ArticleJournal of the American Geriatrics Society2026
Hospital Drug Burden and Post-Discharge Health Care Utilization in Older Adults Prescribed Central Nervous System-Active Medications.
Article in Journal of the American Geriatrics Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe Drug Burden Index (DBI) quantifies cumulative exposure to anticholinergic and sedative medications and can be used to measure medication burden during hospitalization. This study evaluates using automated DBI calculations from electronic health records (EHRs) to track DBI changes during hospitalization, identify high-risk older adults, and assess associations with post-discharge health utilization outcomes.
methodsThis retrospective cohort study used EHRs of patients aged 65+ from three academic health system hospitals (2018-2020), and prescribed central nervous system (CNS)-acting medications around hospitalization (90 days before and after). Logistic regression assessed the associations between DBI at admission, discharge, and changes in DBI during hospitalization with 30-day readmission and discharge destination. Linear regression assessed the relationship between DBI at these time points and 90-day post-discharge outpatient visits.
resultsA total of 3450 eligible patients had complete DBI measurements, with 80% having no change during hospitalization. DBI at admission, discharge, or changes during hospitalization was not associated with 30-day readmission. Any change in DBI, compared to no DBI change, was associated with reduced odds of being discharged home (DBI increase [worsening drug burden] OR: 0.29 [0.21, 0.40]); DBI decrease OR: 0.35 [0.28, 0.43]. High DBIs at admission or discharge were linked to more clinical visits post-discharge, while a DBI increase during hospitalization was associated with fewer visits (RR: 0.86 [0.73-1.00]).
conclusionDBI changes during hospitalization impact discharge disposition and follow-up care needs but not 30-day readmission, highlighting opportunities to optimize medication management during hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.